Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients

Autor: Kf, Bol, Carl Figdor, Eh, Aarntzen, Me, Welzen, Mm, Rossum, Wa, Blokx, Mw, Rakt, Nm, Scharenborg, Aj, Boer, Jm, Pots, Ma, Olde Nordkamp, Tg, Oorschot, Rd, Mus, Sa, Croockewit, Jf, Jacobs, Schuler G, Neyns B, Jm, Austyn, Cj, Punt, Schreibelt G

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::05a9637520e2ca02c2362a62cc3829f5
http://europepmc.org/abstract/med/26405571

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.

Autor: Versteijne E; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., van Dam JL; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Suker M; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Janssen QP; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Groothuis K; Clinical Research Department, Comprehensive Cancer Organisation the Netherlands (IKNL) Nijmegen, the Netherlands., Akkermans-Vogelaar JM; Clinical Research Department, Comprehensive Cancer Organisation the Netherlands (IKNL) Nijmegen, the Netherlands., Besselink MG; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Bonsing BA; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Buijsen J; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Busch OR; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Creemers GM; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands., van Dam RM; Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands.; Department of General, Visceral and Transplant Surgery, University Hospital Aachen, Aachen, Germany.; GROW - School for Oncology and Developmental Biology, Maastricht University, the Netherlands., Eskens FALM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Festen S; Department of Surgery, OLVG, Amsterdam, the Netherlands., de Groot JWB; Department of Medical Oncology, Isala Oncology Center, Zwolle, the Netherlands., Groot Koerkamp B; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., de Hingh IH; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands., Homs MYV; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van Hooft JE; Department of Gastroenterology and Hepatology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands., Kerver ED; Department of Medical Oncology, OLVG, Amsterdam, the Netherlands., Luelmo SAC; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Neelis KJ; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Nuyttens J; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Paardekooper GMRM; Department of Radiation Oncology, Isala Oncology Center, Zwolle, the Netherlands., Patijn GA; Department of Surgery, Isala Oncology Center, Zwolle, the Netherlands., van der Sangen MJC; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands., de Vos-Geelen J; Department of Internal Medicine, Division of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, the Netherlands., Wilmink JW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Zwinderman AH; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Punt CJ; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Centre, Utrecht University, the Netherlands., van Tienhoven G; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., van Eijck CHJ; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Apr 10; Vol. 40 (11), pp. 1220-1230. Date of Electronic Publication: 2022 Jan 27.

Reply to S. Shi et al and G.W. Peters et al.

Autor: van Tienhoven G; Geertjan van Tienhoven, MD, PhD; and Eva Versteijne, MD, Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Aeilko H. Zwinderman, PhD, Department of Clinical Epidemiology and Biostatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Cornelis J. Punt, MD, PhD, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; and Casper H. van Eijck, MD, PhD, Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Versteijne E; Geertjan van Tienhoven, MD, PhD; and Eva Versteijne, MD, Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Aeilko H. Zwinderman, PhD, Department of Clinical Epidemiology and Biostatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Cornelis J. Punt, MD, PhD, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; and Casper H. van Eijck, MD, PhD, Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Zwinderman AH; Geertjan van Tienhoven, MD, PhD; and Eva Versteijne, MD, Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Aeilko H. Zwinderman, PhD, Department of Clinical Epidemiology and Biostatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Cornelis J. Punt, MD, PhD, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; and Casper H. van Eijck, MD, PhD, Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Punt CJ; Geertjan van Tienhoven, MD, PhD; and Eva Versteijne, MD, Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Aeilko H. Zwinderman, PhD, Department of Clinical Epidemiology and Biostatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Cornelis J. Punt, MD, PhD, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; and Casper H. van Eijck, MD, PhD, Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van Eijck CH; Geertjan van Tienhoven, MD, PhD; and Eva Versteijne, MD, Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Aeilko H. Zwinderman, PhD, Department of Clinical Epidemiology and Biostatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Cornelis J. Punt, MD, PhD, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; and Casper H. van Eijck, MD, PhD, Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Sep 01; Vol. 38 (25), pp. 2945-2946. Date of Electronic Publication: 2020 Jun 23.

Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel.

Autor: Huiskens J; Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bolhuis K; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: k.bolhuis@amsterdamumc.nl., Engelbrecht MR; Department of Radiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., De Jong KP; Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kazemier G; Department of Surgery, Amsterdam UMC, VU University, Cancer Center Amsterdam, Amsterdam, The Netherlands., Liem MS; Department of Surgery, Medical Spectrum Twente, Enschede, The Netherlands., Verhoef C; Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands., de Wilt JH; Department of Surgery, Radboud UMC, Nijmegen, The Netherlands., Punt CJ; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van Gulik TM; Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Publikováno v: Journal of the American College of Surgeons [J Am Coll Surg] 2019 Dec; Vol. 229 (6), pp. 523-532.e2. Date of Electronic Publication: 2019 Sep 11.

The impact of data errors on the outcome of randomized clinical trials.

Autor: Buyse M; 1 International Drug Development Institute (IDDI), San Francisco, CA, USA.; 2 Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BioStat), Hasselt University, Hasselt, Belgium., Squifflet P; 3 International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Coart E; 3 International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Quinaux E; 3 International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Punt CJ; 4 Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Saad ED; 3 International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium.

Publikováno v: Clinical trials (London, England) [Clin Trials] 2017 Oct; Vol. 14 (5), pp. 499-506. Date of Electronic Publication: 2017 Jun 22.